AWS’s framework will speed up the analysis of ElevateBio’s large protein datasets, hinting at promising drug candidates.

ElevateBio will leverage artificial intelligence to expand and accelerate CRISPR discovery, design, and drug development for thousands of complex ...

LETI-101 has demonstrated therapeutically relevant reductions of mutant huntingtin (HTT) protein, exceeding 80%, while preserving essential ...

ElevateBio is seeking out partnerships for its lead gene therapy after the construct reduced the levels of a toxic protein in ...

ElevateBio has entered into a multi-year collaboration with Amazon's cloud arm to identify treatment targets and new CRISPR systems.

Cell and gene therapy specialist ElevateBio has taken the total fundraising since it launched five years ago to around $1.25 billion, with its latest $401 million round the largest private ...

New York-based Panther Life Sciences Corp. announced a partnership with Pitt BioForge to advance Panther's Microarray Patch ...

Following the sale, Sinha holds 49,432 shares directly, with additional shares held through ElevateBio, where Sinha serves as a director and Chief Financial Officer. InvestingPro subscribers can ...

ElevateBio will leverage artificial intelligence to expand and accelerate CRISPR discovery, design, and drug development for thousands of complex monogenic and polygenic diseases Generative AI ...

WALTHAM, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- ElevateBio, a technology-driven company focused on powering the creation of life-transforming genetic medicines, announced the presentation of new ...